WALTHAM, Mass., April 30, 2025 /PRNewswire/ -- Q32 Bio Inc. (QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other ...
Adicet Bio (NASDAQ:ACET) on Wednesday said that the U.S. Food and Drug Administration has granted Fast Track Designation to ADI-001 for the potential treatment of relapsed/refractory class III or ...
MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...
(RTTNews) - Intelligent Bio Solutions (INBS),Tuesday announced that its FDA clearance process for the Intelligent Fingerprint Drug Screening System is progressing as planned, with the company on track ...